Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001465825-15-000003

Director acquired 2,000,000 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
NIGALAYE ASHOK G Director 2015-05-21 Conversion +2,000,000 $0.06 $125,000 40,442,232 D
Derivatives
NIGALAYE ASHOK G Director 2015-05-21 Conversion · Warrants −2,000,000 $0.06 $125,000 2,000,000 D
Loading xslF345X03/primary_doc.xml…